Cargando…
AB063. A prostaglandin E (PGE) receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP-PKA/PI3K-AKT signaling pathway
BACKGROUND: Prostate cancer (PCa) is one of the most prevalent diagnosed malignancies in the world. Previous studies have proved that prostaglandin E(2) (PGE(2)) was closely related to the tumorigenesis and progression of PCa. However, the molecular mechanisms are not very clear, and it is necessary...
Autores principales: | Xu, Song, Ge, Jing-Ping, Zhang, Zheng-Yu, Zhou, Wen-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565612/ http://dx.doi.org/10.21037/tau.2017.s063 |
Ejemplares similares
-
AB065. EP4 antagonist suppresses bone metastasis in prostate cancer
por: Xu, Song, et al.
Publicado: (2017) -
AB063. Gore PROPATEN Vascular Graft vs. great saphenous vein graft for aorto-renal artery bypass in pediatric/adolescent patients of Takayasu arteritis
por: Feng, Xiang, et al.
Publicado: (2018) -
AB066. MiR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma
por: Xu, Song, et al.
Publicado: (2017) -
AB064. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer
por: Xu, Song, et al.
Publicado: (2017) -
AB125. The correlation of SRSF1 and survivin in prostate cancer
por: Xiao, Bangming, et al.
Publicado: (2016)